BOR15001L7

· Laboratoire Boreaderme Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BOR15001L7, covering 2020-09-07 to 2020-09-07. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis [Phase 2]

See pricing